Hydroxychloroquine vs Placebo for Prevention of COVID-19 in Health Care Workers | Penn Medicine

Penn Medicine’s Dr. Ravi K. Amaravadi, MD discusses the results of the PATCH (Prevention and Treatment of COVID-19 with HCQ) trial in this lecture during the Penn Medicine Cancer and COVID-19 CME Event featuring Dr. Anthony Fauci. He elaborates on the results within the PATCH trial that included outcomes of a placebo treatment vs. hydroxychloroquine on confirmed COVID-19 patients quarantining at home, hospitalized COVID-19 patients, and health care workers working more than 20 hours a week with direct contact with COVID-19 patients.

Related Links:

Twitter @PennMDForum
Dr. Amaravadi’s physician profile


November 11, 2020

Created by

Penn Physician VideoLink